Prism Medico and Pharmacy Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 1, 2022	Apr '21 Apr 1, 2021	2016 - 2020
Net Income	-0.49	-0.21	-0.76	-3.7	-1.3	Upgrade
Depreciation & Amortization	0.04	0.05	0.07	0.09	0.12	Upgrade
Other Operating Activities	-0.14	0.02	26.58	-1.29	-0.45	Upgrade
Change in Accounts Receivable	1.06	10.72	1.19	86.33	48.22	Upgrade
Change in Inventory	-	-	-	-19.24	-47.99	Upgrade
Change in Accounts Payable	-0.31	0.31	-	-84.44	-0.04	Upgrade
Change in Other Net Operating Assets	-0.33	-10.93	2.47	-1.55	0.92	Upgrade
Operating Cash Flow	-0.17	-0.05	29.54	-23.79	-0.51	Upgrade
Investment in Securities	-	-	-	19.38	-	Upgrade
Investing Cash Flow	-	-	-29.13	23.5	0.24	Upgrade
Other Financing Activities	-0.02	-0.07	-0	-0	-0	Upgrade
Financing Cash Flow	-0.02	-0.07	-0	-0	-0	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-0	-0	-0	Upgrade
Net Cash Flow	-0.18	-0.12	0.41	-0.29	-0.28	Upgrade
Cash Interest Paid	0.02	0.07	0	-	0	Upgrade
Cash Income Tax Paid	-0.02	-0.01	2.68	-	-	Upgrade
Levered Free Cash Flow	0.31	-0.37	-26.04	-17.8	0.38	Upgrade
Unlevered Free Cash Flow	0.31	-0.37	-26.04	-17.8	0.38	Upgrade
Change in Working Capital	0.42	0.09	3.67	-18.89	1.11	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.